Promising Experimental Cancer Vaccine Shows Success in Treating Pancreatic Tumors

An experimental cancer vaccine has been shown to treat four in ten pancreatic tumors, providing a ray of hope for patients with this aggressive disease. In a study With mice, the injection “killed” 43% of pancreatic tumors and prevented the cancers from coming back when they relapsed.

The vaccine uses an insect weakened by food poisoning to stimulate an immune response and contains a part of the recipient’s tumor to train the body to fight its own cancer. While the study is preliminary, the University of Massachusetts team hopes to begin human trials in the coming years.

If approved, it could be a lifesaver for patients diagnosed with pancreatic cancer, a situation that is currently a death sentence in the United States. Only 8.5% of Americans survive more than five years.

Compared to other cancers, pancreatic cancer is quite rare. It is the third leading cause of cancer death in the US, claiming 50,550 lives each year. It is difficult to detect early because the pancreas is located deep within the body, so healthcare providers cannot see or feel the tumors during routine physical exams.

Actor Valentino Lanús reveals that he had cancer and fought it without chemotherapy: I was never afraid of death

Once discovered, it is also difficult to treat because tumors are often surrounded by important tissue, making it difficult for treatments to reach the cancer directly without damaging the tissue.

Initially, the research team will use the vaccine to treat liver cancer, followed by pancreatic cancer. Liver cancer is one of the leading causes of death in the world: more than 700,000 each year.

The new vaccine is made from a molecule extracted from the inside of a cancer cell and wrapped in a protein from a chicken egg called ovalbumin. Vaccines against yellow fever, influenza, MMR and rabies contain small amounts of egg protein because they are grown in chicken eggs.

The molecule and protein are administered into genetically altered salmonella bacteria, which are non-toxic and release the vaccine. When injected into the blood, weakened salmonella bacteria trigger an immune response.

The protein also activates a type of white blood cell called T cells, which trains the immune system to attack future cancer cells. The team tested the treatment in mice with pancreatic cancer.

Diabesity, the epidemic of the 21st century: learn what factors make you more prone to obesity and diabetes

Neil Forbes, professor of Chemical Engineering and senior author of the paper, said: “We had a complete cure in three of the seven pancreatic mouse models. We are very excited about it; “It dramatically expanded survival.”

The researchers then attempted to reintroduce pancreatic tumors into the vaccinated mice. “None of the tumors grew, meaning that the mice had developed immunity not only against the ovalbumin, but also against the cancer itself,” Professor Forbes said.

“The immune system has learned that the tumor is immunogenic. “I’m working harder to figure out how that actually happens,” she added.

The team plans to seek FDA approval to launch clinical trials within a few years. Before trials can begin, they must repeat the experiments on other animals and make sure the salmonella strain is safe for use in humans.

Professor Forbes, whose grandfather died from prostate cancer, said: “This is not just an academic exercise. “I’m really trying to create a cancer therapy.” He study was published last week in the journal Frontiers in Immunology.

In previous research, the team showed that injecting altered salmonella into the blood was effective in treating liver tumors in mice.

Professor Forbes said the new immunotherapy has “the potential to be effective in a wide range of cancer patients”. (YO)

2023-10-14 17:12:00
#Experimental #cancer #vaccine #eliminates #ten #pancreatic #tumors #research #mice #Universo